bipolar Flashcards
Treatment for acute mania
D/C any antidepressants or stimulants
SGAs: aripiprazole, quetiapine, risperidone, asenapine, paliperidone, cariprazine
Lithium
Valproate
2nd:
carbamazepine (safety profile)
olanzapine
ziprasidone
haloperidol
Treatment for bipolar depression
quetiapine
lithium
lamotrigine
lurasidone
2nd:
valproate
olanzapine/fluoxetine
cariprazine
adjunctive SSRI/bupropion (never first line)
1st line maintenance therapy
lithium
valproate
lamotrigine
quetiapine
aripiprazole
asenapine
olanzapine-samidorphan
Lithium CI
pregnancy (cardiac malformations)
breastfeeding
renal impairment (Almost 100% renally eliminated unchanged)
dehydration
hyponatremia
severe cardiac disease
Lithium AE (within therapeutic range)
GI upset
cognitive effects
tremor
polyuria/polydipsia
weight gain
alopecia
leukocytosis
rash
somnolence/sedation
AKI
hypothyroidism
neurotoxicity (SILENT)
Lithium AE (toxicity)
> 1.5 coarse tremor, N/V/D
2.0 confusion, sedation, slurred speech
2.5 seizures, coma, death
Interactions that increase lithium levels
NSAIDs
decreased sodium intake / sodium loss
thiazide diuretics
ACEis, ARBs
calcium channel blockers
dehydration, sweating, diarrhea
prolonged fever
Interactions that decrease lithium levels
Loop diuretics
SGLT-2 inhibitors
carbonic anhydrase inhibitors
excessive sodium intake
excessive fluid intake
theophylline
caffeine
Valproate MoA
enhances inhibitory GABA effects
inhibits voltage-sensitive Na+ channels (decreases glutamate excitatory neurotransmitters)
Valproate CI
hepatic disease
urea cycle disorders
pregnancy (neural tube defects, craniofacial defects, cardiovascular defects)
Valproate AE
N/V
Tremor
sedation
alopecia
weight gain
thrombocytopenia
LFT increase
hepatotoxicity (BBW)
encephalopathy
pancreatitis (BBW)
agranulocytosis
PCOS
metabolic syndrome
rash
Interactions that decrease valproate levels
carbamazepine
phenytoin
rifampin
combined oral contraceptives
Valproate has increased hepatotoxicity risk when combined with
topiramate
Valproate can increases levels of which drugs?
lamotrigine
lorazepam
Carbamazepine MoA
enhances inhibitory GABA effects
inhibits voltage-sensitive Na+ channels (decreases glutamate excitatory neurotransmitters)
inhibits glutamate release
anti-kindling effect